European Drug Report 2021: Trends and Developments
Introduction
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm reduction interventions.
Download as PDF
- Arabic (ar)
- Bulgarian (bg)
- Croatian (hr)
- Czech (cs)
- Danish (da)
- Dutch (nl)
- English (en)
- Estonian (et)
- Finnish (fi)
- French (fr)
- German (de)
- Greek (el)
- Hungarian (hu)
- Italian (it)
- Latvian (lv)
- Lithuanian (lt)
- Norwegian (no)
- Polish (pl)
- Portuguese (pt)
- Romanian (ro)
- Russian (ru)
- Slovakian (sk)
- Slovene (sl)
- Spanish (es)
- Swedish (sv)
- Turkish (tr)
Table of contents
- Preface
- Introductory note
- Acknowledgements
- Director's message
- COVID-19 pandemic and the drug situation
- Latest data on Europe's drug situation
- Cannabis
- Cocaine
- Amphetamine
- Metamphetamine
- MDMA
- New psychoactive substances
- LSD, DMT, mushrooms, ketamine and GHB
- Heroin and other opioids
- Production and precursors
- Drug law offences
- Injecting drug use
- Drug-related infectious diseases
- Drug-induced deaths
- Annex - National data tables